Cherry Pharmaceuticals LLC is categorized under Biological Products Manufacturers in Sugar Land, TX and active since 2011.
Cherry Pharmaceuticals LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact David Cohen at the company’s single location by writing to 2551 Sage Brush Lane, Sugar Land, Texas TX 77479 or by phoning (203) 212-2428. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cherry Pharmaceuticals LLC |
| Contact Person: | David Cohen |
| Address: | 2551 Sage Brush Lane, Sugar Land, Texas 77479 |
| Phone Number: | (203) 212-2428 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Cherry Pharmaceuticals LLC was started in 2011 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Cohen for inquiries that concern Cherry Pharmaceuticals LLC by calling the company number (203) 212-2428, as your correspondence is most welcome. Additionally, the physical location of the single location of Cherry Pharmaceuticals LLC can be found at the coordinates 29.586342,-95.599803 as well as the street address 2551 Sage Brush Lane in Sugar Land, Texas 77479.
For its online presence, you may visit Cherry Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.